Low-grade albuminuria and cardiovascular risk : what is the evidence?
about
The effects of environmental chemicals on renal functionPrevalence of chronic kidney disease after preeclampsia.Physical activity is inversely associated with microalbuminuria in hypertensive patients at high cardiovascular risk: data from I-SEARCH.Microalbuminuria indicates long-term vascular risk in patients after acute stroke undergoing in-patient rehabilitation.Reduction in basal nitric oxide activity causes albuminuriaCandesartan cilexetil/hydrochlorothiazide combination treatment versus high-dose candesartan cilexetil monotherapy in patients with mild to moderate cardiovascular risk (CHILI Triple T).Low-Grade Albuminuria Is Associated with Metabolic Syndrome and Its Components in Middle-Aged and Elderly Chinese Population.Association of cognitive function with albuminuria and eGFR in the general population.Changes in albuminuria predict mortality and morbidity in patients with vascular diseasePresence of Cardiometabolic Risk Factors Is Not Associated with Microalbuminuria in 14-to-20-Years Old Slovak Adolescents: A Cross-Sectional, Population Study.Urine Albumin Excretion Is Associated with Cardiac Troponin T Detected with a Highly Sensitive Assay in a Community-Based Population.Glycated haemoglobin A1c is associated with low-grade albuminuria in Chinese adultsPredictors of cognitive decline in older individuals with diabetes.Association Between Hearing Impairment and Albuminuria in the Korean Adults: The 2011-2012 Korea National Health and Nutrition Examination SurveyAngiotensin blockade to reduce microvascular damage in diabetes mellitus.Urinary Albumin Excretion Reflects Cardiovascular Risk in Postmenopausal Women without Diabetes: The 2011 to 2013 Korean National Health and Nutrition Examination Survey.Hypertension and Diabetes: what are the pros to treating early surrogates?Biomarkers: optimizing treatment guidance in heart failure.Renal sympathetic denervation: applications in hypertension and beyond.Urinary albumin excretion from spot urine samples predict all-cause and stroke mortality in Africans.Efficacy and safety of a fixed-dose combination of lercanidipine and enalapril in daily practice. A comparison of office, self-measured and ambulatory blood pressure.Interrelationship between aortic stiffness and proteinuria in chronic kidney disease.Mortality and morbidity in relation to changes in albuminuria, glucose status and systolic blood pressure: an analysis of the ONTARGET and TRANSCEND studies.Enhanced complement activation is part of the unfavourable cardiovascular risk profile in South Asians.Resting heart rate is associated with renal disease outcomes in patients with vascular disease: results of the ONTARGET and TRANSCEND studies.Associations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.The Effects of Urinary Albumin and Hypertension on All-Cause and Cardiovascular Disease Mortality in Korea.
P2860
Q28397401-5F2C3536-7CFA-4104-BC20-544983C57B00Q33705084-B537EB3D-D4BB-453C-8A1E-969CC595F990Q34013444-9561079D-35AD-482E-A2CA-F55A41718841Q34420494-FA7A15B3-5CCE-4095-A115-FB292C9F206EQ34527146-41C351BB-44C9-449F-AA7E-AAFDA6E95738Q34627724-8DF95B9C-349A-4AA2-A78B-D07A845CCBA1Q34785219-DFB72F6C-2204-4F48-949E-114124F07EBEQ35030627-5332047C-8D79-48E3-BCD4-E4C79423DD31Q35108899-140B0C4C-1250-4681-9ECD-DB343D1913B9Q35654170-1DF676B8-6224-45F1-ABB0-78561C727DE5Q35753558-71F37A5A-EB52-4FD1-BF9B-2CE611508F8DQ35960047-67859AF4-5149-4BC7-ABC2-156780CC484FQ36945266-0645CA5E-CAF4-4A41-9A71-0393319234DCQ37176259-90C4E9D0-862A-4C4D-9E49-D7EF1DFFCEA9Q37369097-54BF5B36-ED73-4EFE-83E1-AFD1E3AF375DQ37541391-A5046925-9DEB-4119-BBAC-4A6410C6DCC6Q37624284-F6C79A65-7B10-4161-8229-7056D2B4BE2EQ37903747-908D0587-1B8D-4114-A096-ACC0854B172BQ38115114-A493E8C2-3BFE-4543-A88C-8524DB6CDDAFQ42237838-4D73CEB3-BF1B-4093-B4A4-8EAD2EEC5DA9Q42620390-21B9BCEB-0907-4055-9820-0972DA9C1DCAQ43182466-946EA9DB-469C-4D05-9ADE-865B9D4A7BC8Q44034435-6C13DB06-E6A6-402A-9F85-D4DDA0C5BD8CQ45025014-DB5C2AF3-EF6F-4016-AFF9-14C8AF7C0A74Q45058890-B16288C9-2861-4B62-BA3A-63B93DE2F0CAQ51582580-EA5005EA-3A8A-4F46-8B76-844CCC1CA2A5Q55224078-29752A9A-FA6A-4208-ACE0-86D8BA0B3F57
P2860
Low-grade albuminuria and cardiovascular risk : what is the evidence?
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Low-grade albuminuria and cardiovascular risk : what is the evidence?
@en
type
label
Low-grade albuminuria and cardiovascular risk : what is the evidence?
@en
prefLabel
Low-grade albuminuria and cardiovascular risk : what is the evidence?
@en
P2093
P2860
P1476
Low-grade albuminuria and cardiovascular risk : what is the evidence?
@en
P2093
Joachim Schrader
Michael Böhm
Roland E Schmieder
Ulrich Tebbe
W Dieter Paar
Walter Zidek
P2860
P2888
P304
P356
10.1007/S00392-007-0510-3
P577
2007-04-26T00:00:00Z